Detalhe da pesquisa
1.
Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers.
Nature
; 596(7870): 126-132, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34290408
2.
Single-cell atlas of epithelial and stromal cell heterogeneity by lobe and strain in the mouse prostate.
Prostate
; 83(3): 286-303, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36373171
3.
Author Correction: Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers.
Nature
; 598(7881): E1, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34608287
4.
Phenotypic characterization of two novel cell line models of castration-resistant prostate cancer.
Prostate
; 81(15): 1159-1171, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34402095
5.
A role for paracrine interleukin-6 signaling in the tumor microenvironment in prostate tumor growth.
Prostate
; 79(2): 215-222, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30345534
6.
MYC drives overexpression of telomerase RNA (hTR/TERC) in prostate cancer.
J Pathol
; 244(1): 11-24, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28888037
7.
Molecular evidence that invasive adenocarcinoma can mimic prostatic intraepithelial neoplasia (PIN) and intraductal carcinoma through retrograde glandular colonization.
J Pathol
; 238(1): 31-41, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26331372
8.
Prostate adenocarcinomas aberrantly expressing p63 are molecularly distinct from usual-type prostatic adenocarcinomas.
Mod Pathol
; 28(3): 446-56, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25216229
9.
Association of pretreatment neutrophil-to-lymphocyte ratio (NLR) and overall survival (OS) in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with first-line docetaxel.
BJU Int
; 114(6b): E11-E17, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24529213
10.
A mouse model of chronic prostatic inflammation using a human prostate cancer-derived isolate of Propionibacterium acnes.
Prostate
; 73(9): 1007-15, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23389852
11.
MYC-driven increases in mitochondrial DNA copy number occur early and persist throughout prostatic cancer progression.
bioRxiv
; 2023 Mar 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36865273
12.
MYC-driven increases in mitochondrial DNA copy number occur early and persist throughout prostatic cancer progression.
JCI Insight
; 8(24)2023 Dec 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37971875
13.
Convergent alterations in the tumor microenvironment of MYC-driven human and murine prostate cancer.
bioRxiv
; 2023 Oct 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37905029
14.
Identifying Phased Mutations and Complex Rearrangements in Human Prostate Cancer Cell Lines through Linked-Read Whole-Genome Sequencing.
Mol Cancer Res
; 20(7): 1013-1020, 2022 07 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35452513
15.
Entinostat Decreases Immune Suppression to Promote Antitumor Responses in a HER2+ Breast Tumor Microenvironment.
Cancer Immunol Res
; 10(5): 656-669, 2022 05 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35201318
16.
IgM anti-ACE2 autoantibodies in severe COVID-19 activate complement and perturb vascular endothelial function.
JCI Insight
; 7(9)2022 05 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35349483
17.
Metabolic programs define dysfunctional immune responses in severe COVID-19 patients.
Cell Rep
; 34(11): 108863, 2021 03 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-33691089
18.
Pervasive promoter hypermethylation of silenced TERT alleles in human cancers.
Cell Oncol (Dordr)
; 43(5): 847-861, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32468444
19.
Metabolic programs define dysfunctional immune responses in severe COVID-19 patients.
medRxiv
; 2020 Oct 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32935120
20.
A high-throughput screen of pharmacologically active compounds for inhibitors of UHRF1 reveals epigenetic activity of anthracycline derivative chemotherapeutic drugs.
Oncotarget
; 10(32): 3040-3050, 2019 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-31105884